featured
Prognostic Value of CTC Count in Metastatic Castration-Resistant Prostate Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Circulating Tumor Cell Counts Are Prognostic of Overall Survival in SWOG S0421: A Phase III Trial of Docetaxel With or Without Atrasentan for Metastatic Castration-Resistant Prostate Cancer
J. Clin. Oncol 2014 Mar 10;[EPub Ahead of Print], A Goldkorn, B Ely, DI Quinn, CM Tangen, LM Fink, T Xu, P Twardowski, PJ Van Veldhuizen, N Agarwal, MA Carducci, JP Monk, RH Datar, M Garzotto, PC Mack, P Lara, CS Higano, M Hussain, IM Thompson, RJ Cote, NJ VogelzangFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.